Skip to main content
Clinical Trials/ISRCTN11510869
ISRCTN11510869
Completed
未知

The effect of moringa oleifera leaf extract on the inflammation status of breast cancer patients receiving aromatase inhibitor therapy

Diponegoro University0 sites78 target enrollmentStarted: December 1, 2022Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Diponegoro University
Enrollment
78

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1\. Breast cancer patient
  • 2\. Post menopause
  • 3\. Imunohistokimia Estrogen receptor (\+), Progesteron receptor (\+)
  • 4\. Received aromatase inhibitor
  • 5\. Patient with Aromatase Inhibitor\-Associated Musculoskeletal Syndrome

Exclusion Criteria

  • 1\. Emergency condition that needs operation
  • 2\. Visceral metastasis
  • 3\. History of previous degenerative joint and soft tissue disease (osteoarthritis/rheumatoid arthritis).
  • 4\. History of fracture during the last 6 months

Investigators

Sponsor
Diponegoro University

Similar Trials